We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Vanguard Total Stock Market ETF | AMEX:VTI | AMEX | Exchange Traded Fund |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.1984 | 0.07% | 268.9284 | 269.589 | 268.49 | 268.62 | 2,046,403 | 19:55:21 |
RNS Number:0567P Virotec International Ld 27 August 2003 Embargoed for release until 7.00am 27 August 2003 VIROTEC INTERNATIONAL LTD SHARE PLACEMENT Virotec International Ltd ("Virotec") announces a Placing (the "Placing") of 25,000,000 new ordinary shares (the "Placing Shares") at a price of GBP 14p (approx AUD 34cents). Chairman and Chief Executive Officer Brian Sheeran explains, "The purpose of this Placing, which raises approximately GBP#3.4 million (approx AUD$8.2 million) net of expenses, is to assist in the implementation and expansion of the Company's strategy and to respond to growing investor interest in the UK. We believe significant market opportunities exist for our wide ranging remediation technologies in the UK and the rest of Europe." The Placing Shares constitute 14.9 per cent of Virotec's current issued share capital. The Placing Shares are being placed with investors by Numis Securities Limited ("Numis Securities"). The Placing is conditional on the admission of the Placing Shares to dealing on the Alternative Investment Market of the London Stock Exchange becoming effective by no later than 8.00 a.m. on 2 September 2003 (or by such later time and date as Numis Securities and Virotec may decide but no later than 9 September 2003). The Placing Shares will rank pari passu in all respects with the existing ordinary shares of Virotec in issue. Application will be made for the 25,000,000 new ordinary shares to be admitted to dealing on the Alternative Investment Market of the London Stock Exchange and to be granted official quotation on the Australian Stock Exchange. It is expected that admission will become effective and dealings will commence on 2 September 2003. Virotec also announces that the unaudited results of the Virotec Group for the year ended 30 June 2003 show revenues of approximately GBP#0.7 million (AUD$1.7 million) and a net loss before tax of approximately GBP#2.3 million (AUD$5.6 million). At 30 June 2003 Virotec had a cash balance of GBP#2.6 million (AUD$6.4 million). Virotec expects to release its full trading results for the year ended 30 June 2003, by mid September 2003. Enquiries: * Angus Craig, Company Secretary, Tel +617 5530 8014 This press release has been issued by Virotec International Ltd, is the sole responsibility of Virotec International Ltd and has been approved as a non-real time financial promotion by Numis Securities Limited of 138 Cheapside, London EC2V 6LH, solely for the purposes of section 21 of the Financial Services and Markets Act 2000. Numis Securities Limited is acting as the financial adviser to Virotec International Ltd and no one else and will not be responsible to any other person for providing the protections afforded to clients of Numis Securities Limited or for providing advice regarding the Placing Virotec International Ltd ABN 81 004801 398 PO Box 188 Sanctuary Cove Queensland 4212 Australia www.virotec.com END This information is provided by RNS The company news service from the London Stock Exchange END IOEPRMMTMMTTMBJ
1 Year Vanguard Total Stock Mar... Chart |
1 Month Vanguard Total Stock Mar... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions